Global Canine atopic dermatitis Market is valued approximately at USD 127.30 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 4.30% over the forecast period 2020-2027. Canine atopic dermatitis is a skin-related issues resulting in allergic symptoms when exposed to allergens. The allergens are usually pollen, dust, and mite types. It is unlikely for pets to be shielded from these allergens since they are exposed to dust mites and pollens while they are outside. Excess scratching, itching, loss of hair, foul odor, rubbing against the carpet, and scaly skin are the common symptoms of this problem. Growing pet ownership across the globe is the factor driving the growth of market over the forecast years. According to the 2019-2020 National Pet Owners Survey conducted by the American Pet Product Association (APPA), over 67 percent of US households or about 85 million families own a pet in the United States, up from 56 percent in 1988. This includes a total of 5.7 million birds, 42.7 million cats, 63.4 million dogs and about 11.5 million freshwater fish, etc. Moreover, according to the 2019 People's Dispensary for Sick Animals (PDSA) Animal Wellbeing (PAW) survey, over 50% of adults in the United Kingdom own a pet, of which over 24% of adults in the United Kingdom own cat, 26% of adults own dogs, and over 2% of adults own rabbits. The ownership of cat in UK increased to 10.9 million in 2019 from 10.3 million in 2017 and similarly dogs ownership rose to 9.9 million in 2019 from 9.3 million in 2017. Additionally, rising research & development activities in the canine atopic dermatitis market is stimulating the growth of market across the globe. However, usage of off-label drugs is hampering the growth of market over the forecast years.

The regional analysis of the global Canine atopic dermatitis Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Europe is the leading region in the global canine atopic dermatitis market due to the rising pet ownership in the region. Whereas, Asia pacific is anticipated to grow with the highest CAGR in the market due to the rising awareness among people regarding canine atopic dermatitis and R&D development in the region.

Major market player included in this report are:
Zoetis
Elanco
Virbac
Toray Industries
AB Science
Boehringer Ingelheim
Kindred Biosciences

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Glucocorticoids
Antihistamines
Immunosuppressants
MAbs
Others

By Mode of administration:
Topical
Oral
Injectable

By Distribution channel:
Veterinary hospitals/clinics
Retail
E-commerce


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018
Base year 2019
Forecast period 2020 to 2027.

Target Audience of the global canine atopic dermatitis market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors